The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada

Trial Profile

The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Sep 2012

At a glance

  • Drugs Influenza A virus H1N1 vaccines (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top